All In Biotech

Drug Trial Radar · NCT03667690

Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis

A Phase 3, Multicenter, Randomized, Double-blind Study of the Efficacy and Safety of Rezafungin for Injection vs. Intravenous Caspofungin Followed by Oral Fluconazole Step Down in the Treatment of Subjects With Candidemia and/or Invasive Candidiasis

Last checked: Nov 19, 2026Latest source record: Jan 6, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 199 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

199

Actual

Start

Oct 7, 2018

Primary completion

Oct 7, 2021

Study completion Oct 7, 2021

Sponsor

Sponsor type
Industry
First posted
Sep 12, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this pivotal study is to determine if intravenous Rezafungin is efficacious and safe in the treatment of candidemia and/or invasive candidiasis when compared to caspofungin (followed by optional oral fluconazole).

Conditions

  • Candidemia
  • Mycoses
  • Fungal Infection
  • Invasive Candidiases

Interventions

  • Rezafungin for InjectionDrug

    Intravenous antifungal therapy

  • CaspofunginDrug

    Intravenous antifungal therapy

  • FluconazoleDrug

    Oral antifungal therapy

  • intravenous placeboDrug

    Normal saline

  • oral placeboDrug

    Microcrystalline cellulose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. All-Cause Mortality (US FDA Only)Time frame: Day 30 (-2 days)
  2. Global Response as Assessed by Data Review Committee (EU European Medicines Agency [EMA] Only)Time frame: Day 14 (±1 day)

Locations

132 sites in 18 countries. Site status is shown where the registry gives one.

  • University of Alabama

    Birmingham, Alabama

  • UC Davis

    Sacramento, California

  • Emory University Hospital

    Atlanta, Georgia

  • Augusta University

    Augusta, Georgia

  • Johns Hopkins

    Baltimore, Maryland

  • Henry Ford Health System

    Detroit, Michigan

  • University of Minnesota

    Minneapolis, Minnesota

  • Mayo Clinic Hospital-Rochester

    Rochester, Minnesota

  • University of Mississippi Medical Center

    Jackson, Mississippi

  • Washington University St. Louis

    St Louis, Missouri

  • Mecury Street Medical

    Butte, Montana

  • University of North Carolina

    Chapel Hill, North Carolina

  • Duke University Medical Center

    Durham, North Carolina

  • ID Clinical Research, Ltd.

    Toledo, Ohio

  • University of Pittsburgh Falk Medical Center

    Pittsburgh, Pennsylvania

  • Reading Hospital and Medical Center

    West Reading, Pennsylvania

  • The University of Texas Health Science Center at San Antonio

    San Antonio, Texas

  • Baylor Scott and White Medical Center

    Temple, Texas

  • Carilion Clinic

    Roanoke, Virginia

  • Alexander Fleming Specialized Medical Institute

    Buenos Aires, Argentina

  • Cordoba Private Hospital

    Córdoba, Argentina

  • Allende Sanatorium

    Córdoba, Argentina

  • Mayo Private Sanatorium

    Córdoba, Argentina

  • Italian Hospital of Mendoza

    Mendoza, Argentina

  • Westmead Public Hospital

    Northmead, New South Wales, Australia

  • Monash Health

    Clayton, Victoria, Australia

  • Peter MacCallum Cancer Centre

    Melbourne, Victoria, Australia

  • Alfred Health

    Melbourne, Victoria, Australia

  • Royal Melbourne Hospital (RMH)

    Parkville, Victoria, Australia

  • Brugmann University Hospital Center

    Brussels, Belgium

  • Erasme Hospital

    Brussels, Belgium

  • University Hospital Brussels

    Brussels, Belgium

  • Saint Luc University Hospital

    Brussels, Belgium

  • University Hospitals Leuven, Campus Gasthuisberg

    Leuven, Belgium

  • Multiprofile Hospital for Active Treatment Puls

    Blagoevgrad, Bulgaria

  • University Multiprofile Hospital for Active Treatment and Emergency Medicine N.I. Pirogov EAD, Sofia, Clinic of Purulent-Septic Surgery

    Sofia, Bulgaria

  • University Multiprofile Hospital for Active Treatment and Emergency Medicine N.I. Pirogov EAD

    Sofia, Bulgaria

  • Huashan Hospital Affiliated Fudan University

    Shanghai, China

  • Shanghai Pulmonary Hospital

    Shanghai, China

  • Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences

    Tianjin, China

Showing 40 of 132 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.